Multi-Asset

Aspiriant Capital Appreciation Fund

Formation2020

CategoryTender Offer Fund

SEC Filing ↗

Net Assets

$146.9M

NAV YoY

−2%

Portfolio Composition

Investment Type

Exchange Traded Fund

2.13%

Mutual Funds

25.07%

Partnership Interests

72.72%

Strategy

Long/Short

42.60%

Public Marketable Securities

27.20%

Private Equity

18.30%

Private Credit

6.40%

Buyout

2.20%

Portfolio composition data sourced from regulatory filings.

Sekond Intelligence

Liquidity RiskB+

Fee Impact1.45%

Quality of Return1.6x

Subscribe to unlock Sekond Intelligence →

Deeper Analysis

Institutional intelligence and portfolio transparency

Reported as of September 2025

Principal Portfolio Holdings

Holding	Value	Allocation
Viking Global Opportunities LP	$14.8M	10.05%
Stripes, LP - Stripes V, LP	$14.0M	9.53%
RA Capital Healthcare Fund, L.P.	$12.9M	8.79%
Proprietary Exposure	---	---
Proprietary Exposure	---	---

Showing 3 of 24 holdings. Pro access required for full portfolio disclosure.

Upgrade to Pro Analysis

Complete Intelligence Layer

Unlock deeper insights including Peer Benchmarking, Historical Performance Attribution, Fee Structure Analysis, and Liquidity Stress Models.

Contact for Firm-Wide Access

About This Fund

The Aspiriant Capital Appreciation Fund is a registered closed-end fund managed by Aspiriant, LLC. It operates as a fund-of-funds structure, investing primarily in alternative Investment Funds across multiple strategies. The fund allocates to private equity, venture capital, credit, hedge funds, and short-term liquidity vehicles, with exposure to U.S. and foreign markets including emerging regions. The fund offers quarterly limited repurchase opportunities and seeks long-term capital appreciation through diversified alternative investments.